Brief: Kinnate Biopharma Inc Reports First Quarter 2023 Financial Results

Kinnate Biopharma

11/05/2023 21:14

May 11 (Reuters) - Kinnate Biopharma Inc  KNTE.O :
    * . REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND RECENT
CORPORATE UPDATES
    * CASH, CASH EQUIVALENTS AND INVESTMENTS OF $231.2 MILLION
AS OF
MARCH 31, 2023 ANTICIPATED TO FUND OPERATIONS INTO EARLY 2025
    * QTRLY LOSS PER SHARE $0.73
    * Q1 EARNINGS PER SHARE VIEW $-0.73 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX8pcnTK 
Further company coverage:  KNTE.O 

 ((Reuters.Briefs@thomsonreuters.com;))